Adaptation‐Proof SARS‐CoV‐2 Vaccine Design

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) surface spike glycoprotein—a major antibody target—is critical for virus entry via engagement of human angiotensin‐converting enzyme 2 (ACE2) receptor. Despite successes with existing vaccines and therapies that primarily target the recept...

Descripción completa

Detalles Bibliográficos
Autores principales: Vishweshwaraiah, Yashavantha L., Hnath, Brianna, Rackley, Brendan, Wang, Jian, Gontu, Abhinay, Chandler, Morgan, Afonin, Kirill A., Kuchipudi, Suresh V., Christensen, Neil, Yennawar, Neela H., Dokholyan, Nikolay V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799234/
https://www.ncbi.nlm.nih.gov/pubmed/36590650
http://dx.doi.org/10.1002/adfm.202206055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799234/
https://www.ncbi.nlm.nih.gov/pubmed/36590650
http://dx.doi.org/10.1002/adfm.202206055

Ejemplares similares